Patent for rapid gene discovery technology:
This article was originally published in Clinica
Myriad Genetics has been granted a US patent covering a technology to speed up the discovery of disease-related genes. The method, called "island hopping", is a way of increasing the rate of sequencing large pieces of DNA by automatically selecting single bands, or islands, of DNA. The technology is used by Salt Lake City-based Myriad to highlight genes and proteins with diagnostic and therapeutic potential through its ProNet protein discovery technology. The company licenses the ProNet technology out to pharmaceuticals companies on a non-exclusive basis.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.